Nkhani Za Kampani
Tsopano Ikupezeka!|Kafukufuku-Galasi ActCel T Cell Activation Reagent - Mayesero Aulere Pazatsopano
Ma cell a T amatenga gawo lofunikira kwambiri pachitetezo cha chitetezo cha mthupi lathu, ndipo chithandizo cha T cell chikuyamba kuchiza matenda monga khansa ndi matenda a autoimmune. Gawo lofunikira mu T cell therapy,T cell activation, zimakhudza mwachindunji zotsatira zachipatala. Ndicho chifukwa chake ndife okondwa kuyambitsa zathuActCel T Cell Activation Reagent (Cat. No. TL-6001-1000)- idapangidwa kuti ikhale yofewa komanso yogwira ntchito kuti ithandizire kuti ma cell azitha kugwira ntchito komanso kukula.
Zofunika Kwambiri
✔️ Otetezeka komanso Ogwira Ntchito: Kutsegula pang'onopang'ono pakukulitsa kwamphamvu kwa ma cell
✔️ Yosavuta Kugwiritsa Ntchito: Mtundu wokonzeka kugwiritsa ntchito
✔️ Zotsika mtengo: Kuchita zodalirika ndi mitengo yampikisano
Webinar Yathu Yaposachedwa: "Kumvetsetsa Autoimmune CAR-T Therapy"
Matenda a Autoimmune ndi vuto lathanzi lapadziko lonse lapansi, lomwe limakhudza pafupifupi 10% ya anthu. Koma bwanji ngati nditakuuzani kuti pali kusintha komwe kungatheke pochiza matendawa?
Ndife okondwa kugawana nawo ma webinar athu aposachedwa, "Kumvetsetsa Autoimmune CAR-T Therapy," yomwe ili ndi Dr. Allan Zhang. Mu gawo lachidziwitso ichi, Dr. Zhang akufufuza zaukadaulo wa CAR-T ndikugwiritsa ntchito kwake mu matenda a autoimmune, kupereka chiyembekezo cha chikhululukiro chopanda mankhwala.
Tikumane ku ESGCT Congress ku Rome!
Ndife okondwa kulengeza kuti T&L Biotechnology ichita nawo msonkhano wa 31st Annual ESGCT Congress, womwe ndi mwambo woyamba wa gene ndi cell therapy.
Osaphonya mwayiwu kukhala nawo pazochitika zosintha. Kuti mudziwe zambiri kapena kukhazikitsa msonkhano, chonde titumizireni mwachindunji. Ndife okondwa kukulandirani ku malo athu ndikukambirana momwe T&L Biotechnology ingathandizire paulendo wanu wasayansi.
Tikuwonani ku Roma!
Kukhazikitsa Kwatsopano | Nanoscale Kusankha Mikanda Yamaginito Yolemera Kwambiri~
Thandizo la ma cell lakula mwachangu m'zaka zaposachedwa pakufufuza zamankhwala ndi chitukuko, ndipo ndi njira yatsopano yopangira mankhwala yomwe yawonetsa kuthekera kwakukulu pochiza matenda monga khansa, matenda opatsirana, komanso matenda odziyimira pawokha.
Uthenga Wabwino | T&L CGT Core Raw Material CD28 Monoclonal Antibody Yamaliza Kulemba kwa FDA DMF
Posachedwapa, Beijing T&L Biotechnology Ltd. (yotchedwa "T&L") idapeza bwino zolembetsa za US FDA DMF za CGT core raw material CD28 monoclonal antibody, yokhala ndi nambala yolembetsa ya DMF 038820.
Uthenga Wabwino | T&L Cell Therapy Key Zida Zalembetsedwa ndi Fda Dmf, Kuthandizira Njira Yanu Yogwiritsira Ntchito Mankhwala
Posachedwapa, Beijing T&L Biotechnology Ltd. (yotchedwa "T&L") idalandira kalata yotsimikizira kuchokera ku US Food and Drug Administration (yomwe imadziwika kuti "FDA"), yofotokoza kuti zida zamakampani zopangira mankhwala a cell, CD3 monoclonal antibody, ndi T cell kusanja kutsegulira maginito mikanda, zamaliza mwalamulo ndi US DMF mtundu II.